Pennsylvania-based
health plan is recognized as a market leader in Dual Special Needs Plans
(D-SNP) for Medicare
Oncology Analytics, a
leading technology-enabled service company that provides health plans,
providers and patients with an evidence-based, real-world analytics approach to
utilization management, purpose-built for oncology, has announced that
Gateway Health,
LLC ("Gateway"), a leading managed care organization
dedicated to caring for the "total health" of its members, has
implemented its utilization management solution for medical oncology.
Oncology
Analytics is currently managing Gateway's Medicare population for oncology
prior authorization requests and will begin managing its Medicaid population
later this year. This includes outpatient, anti-cancer, and supportive
care drugs within both the medical and pharmacy care benefit. By combining the
reviews of both the pharmacy benefit drugs with the medical benefit drugs,
Gateway members are assured of a more complete assessment of their care.
Providers participating in Gateway's network can also conveniently access the
Oncology Analytics platform through single sign-on, using the same credentials
they use for the Gateway Provider Portal. In partnering with Oncology
Analytics, Gateway will also gain access to Oncology Insights™, a real-world
data analytics solution that combines clinical oncology data with Gateway's
health plan data.
"Throughout
the planning process, we quickly discovered that Gateway shares a member-first
approach to benefits management with Oncology Analytics. This common ground is
at the core of our new partnership," said
Eric Yarnell, Vice President of
Pharmacy at Gateway. "Oncology Analytics' real-world data approach to
utilization management is truly unique in the marketplace. We believe that it
will provide significant value and efficiency to Gateway in managing both our
medical and pharmacy benefits."
"Oncology
Analytics is thrilled to welcome Gateway to the family of health plans we are
honored to serve," said
Rick
Dean
, Oncology Analytics' CEO. "Gateway's recognition
of the importance of using real-world data in cancer treatment decisions is
both innovative and admirable. We are proud to play a role in achieving their
mission."
About Oncology Analytics
Oncology Analytics, Inc. provides health plans, providers, and patients with a
data-driven utilization management solution that delivers real-world,
evidence-based analytics focused exclusively for oncology. Used by physicians
to support 5 million health plan members in the US and
Puerto Rico,
the Oncology Analytics e-Prior Authorization platform covers the full spectrum
of therapeutics, across all cancer types and stages, including chemotherapy,
radiation therapy, precision medicine, targeted therapy, and supportive care.
The extensive pathway library is continuously updated with the latest
evidence-based protocols, which provides the most current options for
value-based treatment paths for every patient case. For more information,
please visit
www.oncologyanalytics.com.